|
1.IntroductionMalaria is a major human parasitic disease and affects approximately 40% of the world population.1, 2, 3 The mortality and morbidity from the disease strongly increased in the recent decades. The disease has tremendous effects on the economic development primarily of sub-Saharan countries.1, 2 The control of malaria was declared as a global priority by the World Health Organization2 (WHO). The main reason for this disaster is a rise of worldwide resistances against existing drugs, most of all against chloroquine.1, 2, 3, 4 Chloroquine was the mainstay therapy for decades and is one of the most important drugs used against an infectious disease.5, 6 To address these problems with resistances, more effort is required in the development of novel antimalarials.3, 4 In particular, a better understanding of the molecular mode of action of the active agents is required for the design of structure-based drugs. Halofantrine is a drug that is effective against chloroquine-resistant strains of Plasmodium falciparum 7 and Plasmodium vivax.8 Halofantrine was first synthesized by Colwell 9 in an army research program on malaria, within a large series of phenanthrenes, quinolines, and related arylaminoethanols. The drug is marketed by GlaxoSmithKline under the name Halfan. Halofantrine was also successfully applied in a pediatric study.10 The drug shows enhanced activity in combination with chloroquine11 and is especially prescribed against a high incidence of multidrug resistances. 12 However, the molecular mode of action of halofantrine is not well understood. The drug interferes with the detoxification process of hemoglobin digestion by-products in the cycle of the red blood cell state of the malaria parasite Plasmodium.13, 14, 15, 16, 17, 18 It was shown that protein mutations in P. falciparum confer resistances to halofantrine.19 Recently a crystal structure of a complex of halofantrine and ferriprotoporphyrin IX (FPPIX) was derived and it was found that stacking of the phenanthrene ring of the drug and the porphyrin of the target structure may play a major role in the biological activity.20, 21 Halofantrine inhibits the formation of the malaria pigment hemozoin. Therefore, a selective binding to the small, active growing faces of the hemozoin crystallites may be considered as a mode of action.22, 23 Halofantrine showed essential chemical features in a pharmacophore model for FPPIX-targeting antimalarials.24 New diagnostic techniques are required to elucidate the molecular mode of action of halofantrine in vitro as well as in Plasmodium. Therefore, the fast, easy, and reliable localization of the drug in the biological environment is of high importance. Halofantrine was determined in rat25 and human12, 26 plasma by means of high-performance liquid chromatography (HPLC). However, a localization of halofantrine in life cells with high spatial resolution would be desired to address the specific binding sides of the drugs in Plasmodium. Novel photonic diagnostic techniques were recently developed and exciting results were achieved in biomedical research.27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 The application of such biophotonic techniques has high potential to elucidate the molecular mode of action of halofantrine and to contribute in a structure-based design of new, effective drugs against malaria. 2.Material and Methods2.1.ChemicalsHalofantrine hydrochloride was a kind gift of GlaxoSmithKline and was used without further purification. The systematic IUPAC name of halofantrine is 3-dibutylamino-1-[1,3-dichloro-6-(trifluoromethyl) phenanthren-9-yl]-propan-1-ol. The molecular structure of halofantrine is shown in Fig. 1 . The atomic numbering scheme and the partitioning of the phenanthrene ring in P1, P2 and P3 in Figure 1 is used in the context for the description of the mode assignment. 2.2.SpectroscopyThe Fourier transform (FT) Raman spectrum of halofantrine hydrochloride was recorded with a Bruker FT Raman spectrometer (RFS 100/S) at the macroscopic mode with a spectral resolution of . The instrument was equipped with a Nd:YAG laser ( , estimated laser power at the samples ) as the excitation source and a liquid-nitrogen-cooled germanium detector. The complementary FT IR spectrum of halofantrine hydrochloride was measured as KBr pellet using a Bruker IFS 66 spectrometer equipped with a DTGS (doped triglycerinsulfate) detector and with spectral resolution. UV resonance Raman microspectroscopy was performed with an UV Raman setup (HR800 LabRam, Horiba/Jobin-Yvon, focal length of and a grating) equipped with an Olympus BX41 microscope, UV sensitive video camera, and a liquid- -cooled CCD detector. For UV microscopy, a UV achromatic fused silica/ microspot objective [LMU- -UVB, numerical aperture ] with broad band UVB coating was chosen. Validation of the wave number axis was performed via the Raman signals from Teflon. The excitation wavelength was derived from an intracavity frequency-doubled argon-ion laser (Innova300-MotoFreD, Coherent Inc.). The laser power at the sample was estimated to be . The spectral resolution was . Because the laser wavelength was chosen to excite the sample in an electronic absorption band, it was necessary to carefully avoid any sample destruction. Furthermore, the sample rotation technique37, 38 was applied. 2.3.Density Functional Theory CalculationDensity functional theory (DFT) calculations were performed with Gaussian 03 (revision D.01)39 with Becke’s three-parameter exchange functional40 (B3) as slightly modified by Stephens,41 coupled with the correlation functional of Lee 42 (B3LYP) and B3 in combination with the correlation part of the functional from Perdew and Wang43 and Perdew 44 (B3PW91). Double and triple split valence basis sets of contracted Gaussian functions with polarized and diffuse functions45, 46, 47 were applied. These hybrid exchange correlation functionals provide reliable estimates of experimental frequencies of organic molecules with small root mean square deviations.48, 49, 50, 51, 52, 53 The DFT calculated harmonic vibrational frequencies are typically too large compared with the experimentally observed ones, due to neglect of anharmonicity, incomplete incorporation of electron correlation, and the use of finite basis sets. Fortunately, this overestimation of the calculated harmonic vibrational frequencies is relatively uniform and can be circumvented by applying transferable scaling factors to the harmonic frequencies.48, 54 For the calculations, values of 0.98 for modes below and 0.96 above were applied, in agreement with the literature.54, 55, 56, 57, 58, 59, 60 The calculated Raman activities were transformed into Raman intensities61 and were further convoluted with Gauss-Lorentz-weighted profiles to simulate Raman spectra with finite bandwidth. 3.Results and DiscussionRaman spectroscopy has unique capabilities as diagnostic tool in biomedical research.27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 The method is highly specific for slight environmental changes that have importance in the biological activity of molecules—such as changes in pH,55 water environment,56 or molecular interactions.35, 37 The measurement is fast and does not require further labeling or preparation steps. The combination of a Raman spectrometer with a confocal microscope enables targeting of biological molecules in subcellular compartments with a spatial resolution of approx. .33, 62 Living cells can be studied since water is a weak Raman scatterer and the technique is nondestructive. The sensitivity and selectivity of Raman spectroscopy can be further improved if the excitation wavelength is tuned into the electronic absorption of the molecules.30, 33, 63, 64, 65 Resonance Raman spectroscopy is an extremely capable technique and enables a selective enhancement of the Raman signals of chromophores in complex biological environments.33, 63 Furthermore, the application of UV laser excitation wavelengths causes very strong signal enhancements due to the intrinsic enhancement of the scattering effect and the resonance enhancement of vibrations that are coupled to the electronic transitions.55, 56, 58 Additionally, the Raman signals are spectrally shifted with respect to disturbing fluorescence and it is possible to derive Raman spectra with high contrast within an environment with fluorescing background.58, 66 UV resonance Raman microspectroscopy was applied for a localization of small amounts of antimalarial drugs in plant material.56, 58 3.1.UV Resonance Raman SpectroscopyThe molecular structure of halofantrine (Fig. 1) shows a chromophoric phenanthrene structure that is highly polarizable and causes strong Raman signals [Fig. 2 ]. These Raman intensities can be enhanced by several magnitudes by exploitation of the described UV resonance effect. Halofantrine shows strong absorption bands in the deep UV at approx. .67 Therefore, the laser excitation wavelengths was chosen for the investigation of halofantrine. A strong enhancement of two Raman bands at 1621 and is seen in the UV resonance Raman spectrum [Fig. 2] in comparison with the nonresonant FT Raman spectrum [Fig. 2]. These strongly enhanced Raman signals of halofantrine can be used as marker bands to localize halofantrine in a complex biological environment. The intensities in the spectra in Fig. 2 are normalized to the strongest Raman peaks, respectively, for better illustration. 3.2.DFT Calculation3.2.1.Raman spectraTo interpret the individual Raman bands in more detail, a thorough normal mode assignment is required. High-performance computing facilities nowadays enable a reliable calculation of vibrational spectra of medium-sized biomolecules.33, 58 The DFT calculation of the Raman spectrum of halofantrine is shown in Fig. 3 . The individual Raman bands in the calculated stick spectrum [Fig. 3] were convoluted with line profiles [Fig. 3] for comparison with measured Raman spectra with finite bandwidth [Fig. 3]. One can see that often several normal modes contribute to an individual Raman band. However, the strongest peak in the nonresonant Raman spectrum of halofantrine [Fig. 3] is dominated by one distinct mode at [Fig. 3]. Several weaker normal modes contribute to the wings of the line profile of this band. Two molecular vibrations at and weaker at [Fig. 3] contribute to the Raman peak at [Fig. 3], which is strongly enhanced in the UV resonance Raman spectrum of halofantrine [Fig. 2]. The overall agreement of the calculated Raman spectrum of halofantrine [Fig. 3] and the measurement [Fig. 3] is very good, while the intensity of the band at is underestimated in the calculation. DFT calculations with the hybrid functional B3PW91 were performed to address whether any improvement can be achieved (results are shown in Fig. 4 ). The calculation with B3PW91 shows an improvement of the intensity of the Raman band at ; however, the intensity of the band at is overestimated. The results of the DFT calculations with double [Figs. 4 and 4] and triple [Figs. 4 and 4] split valence basis sets are very similar and no significant basis size effect was found. The calculation with the model chemistry was chosen for further consideration because of the very good agreement in the wavenumber region , where certain Raman modes gain strong UV resonance enhancement. 3.2.2.Electron density distributionThe electron density distribution of halofantrine was calculated and yields fundamental insight regarding the possible binding behavior of the halofantrine molecule. A stacking of the phenanthrene ring of halofantrine with the porphyrin backbone of ferriprotoporphyrin IX (FPPIX) was found20, 21 in a recent crystal structure of an in vitro complex of halofantrine with FPPIX. One should consider whether such binding is possible, due to strongly electron withdrawing substituent’s at the phenanthrene ring of halofantrine. The electron density distribution of halofantrine (Fig. 5 ) highlights the electron withdrawing effect of the substituent’s [C(1)Cl(31) and C(3)Cl(32) as well as C(27)F(28)F(29)F(30)]. However, a strong and evenly distributed electron density remains across the phenanthrene ring. This result supports the hypothesis that stacking may play an important role in the biological activity of halofantrine. 3.3.Mode Assignment and Atomic DisplacementsThe ultimate goal of the Raman spectroscopic investigation of halofantrine is a localization of the drug at the binding side of the biological target in life cells and an elucidation of changes in the Raman spectrum, caused by molecular interactions. To enable a discussion of such changes in the Raman bands of halofantrine, caused by changes in the environment, a detailed interpretation of the individual Raman bands is required. The DFT calculations can be used for a thorough band assignment. The calculations of the atomic displacements of the molecular normal modes provide much deeper understanding of the associated Raman bands. The Raman spectrum of halofantrine consists of two well separated parts above and below (see Fig. 6 ). The range with high wave number values consist of two separated parts: a region with CH-stretching vibrations at the phenanthrene ring and an area with , stretching vibrations at the side chain of halofantrine. In addition, there is also one OH stretching vibration present at . However, the fingerprint region of halofantrine (below ) is of more importance in the further discussion. The graphical illustration of the atomic displacements of two prominent modes at 1621 and are shown in Figs. 7 and 7 , respectively. The assignment of more Raman bands of halofantrine is summarized in Table 1 . Table 1Mode assignment and wave number values of prominent Raman bands of halofantrine [Figs. 2, 3, 6].
The assignment was performed with help of DFT calculation
[B3LYP∕6–311+G(d,p)]
. The atomic numbering scheme, as shown in Fig. 1, is used for the assignment. The atomic displacements of the prominent mode at
1622cm−1
, which is strongly enhanced with UV excitation
λexc=244nm
[Fig. 2], is shown in Fig. 5. The atomic displacements of the strongest mode in the non-resonant Raman spectrum [Fig. 2] at
1349cm−1
is shown in Fig. 7. The strongest peak in the UV resonance Raman spectrum of halofantrine (Fig. 1) is found at wavenumber position [Fig. 2]. This band is assigned to a very strong, combined -stretching vibration at the phenanthrene ring. The atomic displacement of the mode is displayed in Fig. 7. The strongest contribution to this normal mode arises from in P2 (see Fig. 1 for numbering scheme) as well as from at the connection of the side chain of the molecule and . A highly symmetric vibration is seen across the phenanthrene ring, where , , , , , and stretch in phase, with a parallel, out-of-phase movement of the pairs {C(4), C(7)} and {C(12), C(9)} toward each other, respectively. Further bending contributions take place , and weaker and . The fluorine atoms F(28), F(29), and F(30) and chlorine atoms Cl(31) and Cl(32) are fixed in space. There are no contributions from the side chain. The very strong enhancement of this mode in the UV resonance Raman spectrum [Fig. 2] is very promising, since this combined -stretching vibration is likely to be influenced by stacking of the phenanthrene ring to the porphyrin ring of biological target structures.20, 21 The calculation of the electron density distribution of halofantrine supports the hypothesis of such interaction. The monitoring of changes in this Raman band during the drug-target interaction might yield novel insight into proposed biological activities of halofantrine. The strongest band in the nonresonant Raman spectrum is seen at wavenumber position [Fig. 2]. Two different snapshots of the atomic displacement of this mode are illustrated in Fig. 7. The normal mode consists of a very strong, combined CC-stretching vibration at the phenanthrene ring, an in-phase breathing vibration at [C(4)C(13), C(7)C(12)] of P1, P2, and P3; combined with a deformation mode [see Fig. 7]. The symmetric narrowing of the ring system at C(4)C(13) and C(7)C(12) is nicely illustrated in the two snapshots of the molecular vibration in Fig. 7. More contributions to this mode arise from and as well as very strong , , , and and medium , , and vibrations. Small contributions are present at the side chain. 3.4.IR SpectroscopyThe IR and Raman spectra of halofantrine yield complementary information. Highly symmetric -stretching vibrations in the phenanthrene ring [e.g., Figs. 7 and 7] posses strong changes in polarizability and cause intense bands in the Raman spectrum (Figs. 2 and 3). On the other hand, polar functional groups in the halofantrine molecule cause weak Raman signals, but very strong IR bands. All IR and Raman bands of halofantrine are shown in Fig. 6. The wave number values of some prominent IR and Raman bands are given in the Figs. 6 and 6, respectively. The strongest IR bands of halofantrine are seen at wave number values 2961, 1320, 1147, 1126, 1082, and . The atomic displacement of the very strong IR mode at is exemplarily shown in Fig. 8 . This mode represents a combined, asymmetric -stretching vibration in the butyl part of the side chain of halofantrine. 4.Conclusion and OutlookThe vibrational spectra of halofantrine, an active agent against multidrug-resistant strains of the malaria parasite Plasmodium, were analyzed by means of nonresonant Raman, UV resonance Raman, and IR spectroscopy as well as DFT calculations. The comparison of the nonresonant Raman spectra and UV resonance Raman spectra (Fig. 2) showed that distinct Raman bands at 1621 and can be enhanced with excitation wavelength . UV resonance Raman spectra are many orders of magnitude stronger than conventional Raman spectra due to the dependency of the scattering effect and the selective resonance enhancement. The discovery of these signal enhancements is the basis for continuing experiments that will address a localization of small concentrations of halofantrine in a biological environment. Raman microspectroscopy has unique capabilities to derive molecular information with submicrometer spatial resolution in life cells. It was possible to identify strong, combined -stretching vibrations in the phenanthrene ring of halofantrine by means of a thorough mode assignment of the Raman spectra of halofantrine. These vibrations are considered as putative marker bands for interactions with the porphyrin ring of biological target structures. The calculation of the electron density indicates a strong and even distribution across the phenanthrene ring, despite the electron withdrawing effect of the Cl and substituents. The electron density calculation supports the hypothesis that interactions play an important role in the molecular mode of action of halofantrine. Further experiments are underway to monitor changes of the putative Raman marker bands during the drug-target binding process. These results will shed more light on suggested models for the biological activity of halofantrine.20, 21 A better elucidation of the molecular mode of action of halofantrine will assist in structure-based design of new, effective antimalarials. AcknowledgmentsThe authors gratefully acknowledge that computations were run at the computing center of the University Leipzig. Halofantrine was a kind gift of GlaxoSmithKline. ReferencesR. W. Snow, C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay,
“The global distribution of clinical episodes of Plasmodium falciparum malaria,”
Nature, 434
(7030), 214
–217
(2005). https://doi.org/10.1038/nature03342 0028-0836 Google Scholar
B. Witkowski, A. Berry, and F. Benoit-Vical,
“Resistance to antimalarial compounds: Methods and applications,”
Drug Resist Update, 12 42
–50
(2009). https://doi.org/10.1016/j.drup.2009.01.001 Google Scholar
R. G. Ridley,
“Medical need, scientific opportunity and the drive for antimalarial drugs,”
Nature, 415 686
–693
(2002). https://doi.org/10.1038/415686a 0028-0836 Google Scholar
I. M. Hastings, P. G. Bray, and S. A. Ward,
“A requiem for chloroquine,”
Science, 298 74
–74
(2002). https://doi.org/10.1126/science.1077573 0036-8075 Google Scholar
T. E. Wellems,
“Plasmodium chloroquine resistance and the search for a replacement antimalarial drug,”
Science, 298 124
–126
(2002). https://doi.org/10.1126/science.1078167 0036-8075 Google Scholar
T. Weinke, H. D. Notdurft, H. Kretschmer, K. Fleischer, T. Loscher, B. Braendli, K. Markwalder, T. Schlunk, R. Clemens, and H. L. Bock,
“Halofantrine in the treatment of imported malaria in non-immune travellers,”
Dtsch. Med. Wochenschr., 118 254
–259
(1993). https://doi.org/10.1055/s-2008-1059324 0012-0472 Google Scholar
J. K. Baird, H. Basri, B. Subianto, D. J. Fryauff, P. D. McElroy, B. Leksana, T. L. Richie, S. Masbar, F. S. Wignall, and S. L. Hoffman,
“Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine,”
J. Infect. Dis., 171 1678
–1682
(1995). 0022-1899 Google Scholar
W. T. Colwell, V. Brown, P. Christie, J. Lange, C. Reece, and K. Yamamoto,
“Antimalarial arylaminopropanols,”
J. Med. Chem., 15 771
–775
(1972). https://doi.org/10.1021/jm00277a018 0022-2623 Google Scholar
P. Minodier, G. Noel, M. Salles, K. Retornaz, H. Walters, J. C. Combes, and J. M. Garnier,
“Mefloquine versus halofantrine in children suffering from acute uncomplicated falciparum malaria,”
Arch. Pediatr., 12 S67
–71
(2005). https://doi.org/10.1016/S0929-693X(05)80017-X 0929-693X Google Scholar
N. Singh and S. K. Puri,
“Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model,”
Life Sci., 67 1345
–1354
(2000). https://doi.org/10.1016/S0024-3205(00)00728-1 0024-3205 Google Scholar
Y. T. Kolade, C. P. Babalola, and G. K. E. Scriba,
“Analysis of the antimalarial drug halofantrine and its major metabolite N-desbutylhalofantrine in human plasma by high performance liquid chromatography,”
J. Pharm. Biomed. Anal., 41 315
–319
(2006). https://doi.org/10.1016/j.jpba.2005.11.002 0731-7085 Google Scholar
M. Foley and L. Tilley,
“Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents,”
Pharmacol. Ther., 79
(1), 55
–87
(1998). https://doi.org/10.1016/S0163-7258(98)00012-6 0163-7258 Google Scholar
S. E. Francis, D. J. Sullivan Jr., D. E. Goldberg,
“Hemoglobin metabolism in the malaria parasite Plasmodium falciparum,”
Annu. Rev. Microbiol., 51 97
–123
(1997). https://doi.org/10.1146/annurev.micro.51.1.97 0066-4227 Google Scholar
L. M. B. Ursos and P. D. Roepe,
“Chloroquine resistance in the malaria parasite Plasmodium falciparum,”
Med. Res. Rev., 22
(5), 465
–491
(2002). https://doi.org/10.1002/med.10016 0198-6325 Google Scholar
J. Wiesner, R. Ortmann, H. Jomaa, and M. Schlitzer,
“Neue Antimalaria-Wirkstoffe,”
Angew. Chem., 115 5432
–5451
(2003). https://doi.org/10.1002/ange.200200569 0044-8249 Google Scholar
H. Matile, R. G. Ridley, and D. E. Goldberg,
“A common mechanism for blockade of heme polymerization by antimalarial quinolines,”
J. Biol. Chem., 273 31103
–31107
(1998). https://doi.org/10.1074/jbc.273.47.31103 0021-9258 Google Scholar
I. Y. Gluzman, D. G. Russell, and D. E. Goldberg,
“On the molecular mechanism of chlorquine's antimalarial action,”
Proc. Natl. Acad. Sci. U.S.A., 93 11865
–11870
(1996). https://doi.org/10.1073/pnas.93.21.11865 0027-8424 Google Scholar
M. B. Reed, K. J. Sallba, S. R. Carusana, K. Kirk, and A. F. Cowman,
“Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum,”
Nature, 403 906
–909
(2000). https://doi.org/10.1038/35002615 0028-0836 Google Scholar
K. A. de Villiers, H. M. Marques, and T. J. Egan,
“The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials,”
J. Inorg. Biochem., 102 1660
–1667
(2008). https://doi.org/10.1016/j.jinorgbio.2008.04.001 0162-0134 Google Scholar
K. A. de Villiers and T. J. Egan,
“Recent advances in the discovery of Haem-targeting drugs for malaria and schistosomiasis,”
Molecules, 14 2868
–2887
(2009). https://doi.org/10.3390/molecules14082868 1420-3049 Google Scholar
S. Pagola, P. W. Stephens, D. S. Bohle, A. D. Kosar, and S. K. Madsen,
“The structure of malaria pagment β-haematin,”
Nature, 404 307
–310
(2000). https://doi.org/10.1038/35005132 0028-0836 Google Scholar
R. Buller, M. L. Peterson, Ö. Almarsson, and L. Leisirowitz,
“Quinoline binding site on malaria pigment crystal: a rational pathway for antimalaria drug design,”
Cryst. Growth Des., 2 553
–562
(2002). https://doi.org/10.1021/cg025550i 1528-7483 Google Scholar
B. N. Acharya and M. P. Kaushik,
“Pharmacophore-based predictive model generation for potent antimalarials targeting haem detoxification pathway,”
Med. Chem. Res., 16 213
–229
(2007). https://doi.org/10.1007/s00044-007-9025-8 Google Scholar
A. Amponsaa-Karikari, N. Kishikawa, K. Ohyama, K. Nakashima, and N. Kuroda,
“Determination if halofantrine and its main metabolite desbutylhalofantrine in rat plasma by high-performance liquid chromatography with on-line UV irradiation and peroxyoxalate chemilumuinescence detection,”
Biomed. Chromatogr., 23 101
–106
(2009). https://doi.org/10.1002/bmc.1094 0269-3879 Google Scholar
Y. T. Kolade, C. P. Babalola, A. A. Olaniyi, and G. K. E. Scriba,
“Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine,”
Eur. J. Clin. Pharmacol., 64 77
–81
(2008). https://doi.org/10.1007/s00228-007-0387-0 0031-6970 Google Scholar
D. Graham and V. Deckert,
“Editorial–a light diagnosis,”
Analyst, 134 1027
–1028
(2009). https://doi.org/10.1039/b907715b 0003-2654 Google Scholar
C. Krafft, B. Dietzek, and J. Popp,
“Raman and CARS microspectroscopy of cells and tissues,”
Analyst, 134 1046
–1057
(2009). https://doi.org/10.1039/b822354h 0003-2654 Google Scholar
C. Kendall, M. Isabelle, F. Bazant-Hegemark, J. Hutchings, L. Orr, J. Babrah, R. Baker, and N. Stone,
“Vibrational spectroscopy: a clinical tool for cancer diagnostics,”
Analyst, 134 1029
–1045
(2009). https://doi.org/10.1039/b822130h 0003-2654 Google Scholar
T. Frosch, S. Koncarevic, K. Becker, and J. Popp,
“Morphology-sensitive Raman modes of the malaria pigment hemozoin,”
Analyst, 134 1126
–1132
(2009). https://doi.org/10.1039/b821705j 0003-2654 Google Scholar
Vibrational Spectroscopy for Medical Diagnosis, Wiley, New York
(2008). Google Scholar
P. Lasch and J. Kneipp, Biomedical Vibrational Spectroscopy, Wiley-VCH, Hoboken, NJ
(2008). Google Scholar
T. Frosch, S. Koncarevic, L. Zedler, M. Schmitt, K. Schenzel, K. Becker, and J. Popp,
“In situ localization and structural analysis of the malaria pigment hemozoin,”
J. Phys. Chem. B, 1
(37), 11047
–11056
(2007). https://doi.org/10.1021/jp071788b 1089-5647 Google Scholar
L. Puskar, R. Tuckermann, T. Frosch, J. Popp, V. Ly, D. McNaughton, and B. Wood,
“Raman acoustic levitation spectroscopy of red blood cell and Plasmodium falciparum trophozoites,”
Lab Chip, 7 1125
–1131
(2007). https://doi.org/10.1039/b706997a 1473-0197 Google Scholar
T. Frosch, B. Küstner, S. Schlücker, A. Szeghalmi, M. Schmitt, W. Kiefer, and J. Popp,
“In vitro polarization-resolved resonance Raman studies of the interaction of hematin with the antimalarial drug chloroquine,”
J. Raman Spectrosc., 35 819
–821
(2004). https://doi.org/10.1002/jrs.1252 0377-0486 Google Scholar
C. Krafft, P. Roesch, and J. Popp, Handbook of Molecular Biophysics, Wiley-VCH, Hoboken, NJ
(2009). Google Scholar
T. Frosch, T. Meyer, M. Schmitt, and J. Popp,
“Device for Raman difference spectroscopy,”
Anal. Chem., 79 6159
–6166
(2007). https://doi.org/10.1021/ac070440+ 0003-2700 Google Scholar
W. Kiefer,
“Raman difference spectroscopy with the rotating cell,”
Appl. Spectrosc., 27 253
(1973). https://doi.org/10.1366/000370273774333452 0003-7028 Google Scholar
M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez, and J. A. Pople, Gaussian 03, Revision D.01, Gaussian, Inc., Wallingford, CT
(2004). Google Scholar
A. D. Becke,
“Density-functional thermochemistry. II. The effect of the Perdew-Wang generalized-gradient correlation correction,”
J. Chem. Phys., 97 9173
–9177
(1992). https://doi.org/10.1063/1.463343 0021-9606 Google Scholar
A. D. Becke,
“Density-functional thermochemistry. III. The role of exact exchange,”
J. Chem. Phys., 98 5648
–5652
(1993). https://doi.org/10.1063/1.464913 0021-9606 Google Scholar
P. J. Stephens, F. J. Devlin, C. F. Chabalowski, and M. J. Frisch,
“Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields,”
J. Phys. Chem., 98 11623
(1994). https://doi.org/10.1021/j100096a001 0022-3654 Google Scholar
C. Lee, W. Yang, and R. G. Parr,
“Development of the Colle-Salvetti correlation-energy formula into a function of the electron density,”
Phys. Rev. B, 37 785
(1998). https://doi.org/10.1103/PhysRevB.37.785 0163-1829 Google Scholar
J. P. Perdew and Y. Wang,
“Accurate and simple analytic representation of the electron-gas correlation energy,”
Phys. Rev. B, 45 13244
(1992). https://doi.org/10.1103/PhysRevB.45.13244 0163-1829 Google Scholar
J. P. Perdew, J. A. Chevary, S. H. Vosko, K. A. Jackson, M. R. Pederson, D. J. Singh, and C. Fiolhais,
“Atoms, molecules, solidas, and surfaces: Applications of the generalized gradient approximation for exchange and correlation,”
Phys. Rev. B, 46 6671
(1992). https://doi.org/10.1103/PhysRevB.46.6671 0163-1829 Google Scholar
J. A. Pople, H. B. Schlegel, R. Krishnan, D. J. Defrees, J. S. Binkley, M. J. Frisch, and R. A. Whitside,
“Molecular orbital studies of vibrational frequencies,”
Int. J. Quantum Chem., 15 269
–278
(1981). 0020-7608 Google Scholar
M. J. Frisch, J. A. Pople, and J. S. Binkley,
“Self-consistent molecular orbital methods 25. Supplementary functions for Gaussian basis sets,”
J. Chem. Phys., 80
(7), 3265
–3269
(1984). https://doi.org/10.1063/1.447079 0021-9606 Google Scholar
W. J. Hehre, R. F. Stewart, and J. A. Pople,
“Self-consistent molecular-orbital methods. I. Use of Gaussian expansions of slater-type atomic orbitals,”
J. Chem. Phys., 51
(6), 2657
–2664
(1969). https://doi.org/10.1063/1.1672392 0021-9606 Google Scholar
A. P. Scott and L. Radom,
“Harmonic vibrational frequencies: An evaluation of Hartree-Fock, Møller-Plesset, quadratic configuration interaction, density functional theory, and semiempirical scale factors,”
J. Phys. Chem., 100 16502
–16513
(1996). https://doi.org/10.1021/jp960976r 0022-3654 Google Scholar
A. A. El-Azhary and H. U. Suter,
“Comparison between optimized geometries and vibration frequencies calculated by the DFT methods,”
J. Phys. Chem., 100 15056
–15063
(1996). https://doi.org/10.1021/jp960618o 0022-3654 Google Scholar
J. Baker, A. A. Jarzecki, and P. Pulay,
“Direct scaling of primitive valence force constants: An alternative approach to scaled quantum mechanical force fields,”
J. Phys. Chem. A, 102 1412
–1424
(1998). https://doi.org/10.1021/jp980038m 1089-5639 Google Scholar
G. Rauhut and P. Pulay,
“Transferable scaling factors for density functional derived vibrational force fields,”
J. Phys. Chem., 99 3093
–3100
(1995). https://doi.org/10.1021/j100010a019 0022-3654 Google Scholar
M. D. Halls and B. Schlegel,
“Comparison of the performance of local, gradient-corrected, and hybrid density functional models in predicting infrared intensities,”
J. Chem. Phys., 109
(24), 10587
–10593
(1998). https://doi.org/10.1063/1.476518 0021-9606 Google Scholar
M. P. Andersson and P. Uvdal,
“New scale factors for harmonic vibrational frequencies using the B3LYP density functional method with the triple-ζ basis set 6–311+G(d,p),”
J. Phys. Chem. A, 109 2937
–2941
(2005). https://doi.org/10.1021/jp045733a 1089-5639 Google Scholar
C. W. Bauschlicher and S. R. Langhoff,
“The calculation of accurate harmonic frequencies of large molecules: the polycyclic aromatic hydrocarbons, a case study,”
Spectrochim. Acta, Part A, 53 1225
–1240
(1997). https://doi.org/10.1016/S1386-1425(97)00022-X 0584-8539 Google Scholar
T. Frosch, M. Schmitt, G. Bringmann, W. Kiefer, and J. Popp,
“Structural analysis of the anti-malaria active agent chloroquine under physiological conditions,”
J. Phys. Chem. B, 111
(7), 1815
(2007). https://doi.org/10.1021/jp065136j 1089-5647 Google Scholar
T. Frosch, M. Schmitt, and J. Popp,
“In situ UV resonance Raman micro-spectroscopic localization of the antimalarial quinine in cinchona bark,”
J. Phys. Chem. B, 111
(16), 4171
–4177
(2007). https://doi.org/10.1021/jp066999f 1089-5647 Google Scholar
T. Frosch, M. Schmitt, and J. Popp,
“Raman spectroscopic investigation of the antimalarial agent mefloquine,”
Anal. Bioanal. Chem., 387 1749
–1757
(2007). https://doi.org/10.1007/s00216-006-0754-1 1618-2642 Google Scholar
T. Frosch, M. Schmitt, T. Noll, G. Bringmann, K. Schenzel, and J. Popp,
“Ultrasensitive in situ tracing of the alkaloid dioncophylline A in the tropical liana triphyophyllum peltatum by applying deep-UV resonance Raman microscopy,”
Anal. Chem., 79
(3), 986
–993
(2007). https://doi.org/10.1021/ac061526q 0003-2700 Google Scholar
T. Frosch, M. Schmitt, K. Schenzel, J. H. Faber, G. Bringmann, W. Kiefer, and J. Popp,
“In vivo localization and identification of the antiplasmodial alkaloid dioncophylline A in the tropical Liana triphyophyllum peltatum by a combination of fluorescence, near infrared Fourier transform Raman microscopy and density functional theory calculations,”
Biopolymers, 82
(4), 295
–300
(2006). https://doi.org/10.1002/bip.20459 0006-3525 Google Scholar
T. Frosch and J. Popp,
“Relationship between molecular structure and Raman spectra of quinolines,”
J. Mol. Struct., 924–926 301
–308
(2009). https://doi.org/10.1016/j.molstruc.2008.12.019 0022-2860 Google Scholar
D. A. Long, The Raman Effect, Wiley, New York
(2002). Google Scholar
G. J. Puppels, F. F. M. De Mul, C. Otto, J. Greve, M. Robert-Nicoud, D. J. Arndt-Jovin, and T. M. Jovin,
“Studying single living cells and chromoscomes by confocal Raman microspectroscopy,”
Nature, 347 301
–303
(1990). https://doi.org/10.1038/347301a0 0028-0836 Google Scholar
Biological Applications of Raman Spectroscopy, 1–3 Wiley, New York
(1988). Google Scholar
R. Petry, M. Schmitt, and J. Popp,
“Raman spectroscopy: A prospective tool in the life sciences,”
ChemPhysChem, 4 14
(2003). https://doi.org/10.1002/cphc.200390004 1439-4235 Google Scholar
Handbook of Vibrational Spectroscopy. Vol. 5. Applications in Life, Pharmaceutical and Natural Sciences, Wiley & Sons, Chichester, UK
(2002). Google Scholar
T. Frosch, N. Tarcea, M. Schmitt, H. Thiele, F. Langenhorst, and J. Popp,
“UV Raman imaging-a promising tool for astrobiology: comparative Raman studies with different excitation wavelengths on SNC martian meteorites,”
Anal. Chem., 79 1101
–1108
(2007). https://doi.org/10.1021/ac0618977 0003-2700 Google Scholar
A. Taillardat-Bertschinger, C. S. Pery, A. Galland, R. J. Prankerd, and W. N. Charman,
“Partitioning of halofantrine hydrochloride between water, Micellar solutions, and soybean oil: Effects on its apparent ionization constant,”
J. Pharm. Sci., 92 2217
–2228
(2003). https://doi.org/10.1002/jps.10479 0022-3549 Google Scholar
|